1.87% -0.17

Avalo Therapeutics Inc (AVTX)

Panoramica Notizia Cronologia dei prezzi Financials Perché AVTX Giù? Forum Previsione Frazionamento azionario

Avalo Therapeutics Inc Azioni (AVTX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	100.00% -	0.571	0.236	0.643	0.475
Cost Of Revenue	63.80% -0.08	-0.221	0.247	0.708	0.551
Costs And Expenses	298.19% 32.77	8.229	3.986	7.793	9.267
Operating Income/Loss	327.88% -32.77	-7.658	-3.75	-7.15	-8.792
Nonoperating Income/Loss	16,955% -88.52	-0.519	-1.47	-1.036	-1.155
Income/Loss From Continuing Operations Before Tax	1,383% -121.28	-8.177	-5.22	-8.186	-9.947
Income Tax Expense/Benefit, Deferred	177.78% 0.007	-0.009	0.008	0.007	0.008
Income Tax Expense/Benefit	177.78% 0.007	-0.009	0.008	0.007	0.008
Income/Loss From Continuing Operations After Tax	1,385% -121.29	-8.168	-5.228	-8.193	-9.955
Net Income/Loss	1,385% -121.29	-8.168	-5.228	-8.193	-9.955
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	103.58% 0.8594	-24.00	46.76	13.97	11.72
Basic Earnings Per Share	24.73% -141.00	-113.04	-0.11	-0.59	-0.85
Diluted Earnings Per Share	24.73% -141.00	-113.04	-0.11	-0.59	-0.85
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%